Endocrine Abstracts

This article discusses the assessment of quality of life, psychological state and anxiety-depressive disorders in patients with metabolic syndrome. It is known that the prevalence of metabolic syndrome in different countries is about 30% and varies from included criteria. The problem of the quality of life of obese and overweight patients is relevant and socially significant. Research Methods The authors present the results of a study of 70 patients with MS and 36 apparently h...

Metabolic syndrome (MS) is a widespread clinical syndrome, the incidence of which is increasing annually in both developing and developed countries. The prevalence of MS among the working population is quite high (20-25%) and tends to increase. The presence of MS increases the risk of developing type II diabetes and cardiovascular diseases, and anxiety and depression are considered as independent risk factors for the development of MS. It has also been found that the prevalenc...

Metabolic syndrome (MS) is a pressing problem of modern medicine. The prevalence of MS has a worldwide tendency to increase and depends on many factors, which explains the difficulty in diagnosis, prevention programs and treatment of this pathology. It has been established that MS has a multifactorial etiology, in which psycho-social factors, genetic and environmental factors are important. At the subclinical stage, functional and biochemical changes associated with MS are rev...

Introduction: Metabolic syndrome (MS) is a common disease with up to 25% of the total adult population and more than 45% of those over 60 years of age. When MS develops a complex of metabolic disorders that contribute to the development of vascular atherosclerotic diseases, such as abdominal obesity, hypertension, insulin resistance, dyslipidemia. Exchange disorders in MS are associated with the development of inflammation in organs and vessels, while the role of neutrophils i...

Introduction: Metabolic syndrome (MS) is a disease that develops in obesity in adult patients with the development of numerous metabolic and vascular disorders. In patients with MS, the risk of developing cardiovascular diseases is increased compared to the general population by 1.78 times as a whole and 2.25 times in women. Currently, the number of overweight children and the development of metabolic complications such as fatty liver, hypertension, and type 2 diabetes are inc...

The defeat of the metabolic syndrome (MS) of young people with the development of severe vascular and diabetic complications determines the relevance of its study for the purpose of early diagnosis. Changes in blood at the preclinical stage of MS are reversible, while the main pathogenetic factors of MS are insulin resistance and dyslipidemia. The aim of the study was to assess the role of biochemical parameters in the pathogenesis of MS.Materials and me...

Metabolic syndrome (MS) is one of the most pressing problems of modern medicine. MS is a symptom complex of impaired carbohydrate metabolism, abdominal obesity, dyslipidemia, hypertension with an increased risk of developing cardiovascular diseases and type 2 diabetes mellitus. The main reasons for the increase in the incidence of MS are a decrease in physical activity and a high-calorie diet. The prevalence of MS in different countries is 25–30% and varies depending on t...